- All sections
- C - Chemistrymetallurgy
- C40B - Combinatorial chemistrylibraries, e.g. chemical libraries
- C40B 50/06 - Biochemical methods, e.g. using enzymes or whole viable microorganisms
Patent holdings for IPC class C40B 50/06
Total number of patents in this class: 1254
10-year publication summary
|
72
|
63
|
81
|
84
|
92
|
89
|
83
|
66
|
82
|
56
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Illumina, Inc. | 3396 |
43 |
| BGI Shenzhen | 539 |
38 |
| MGI Tech Co., Ltd | 442 |
31 |
| BGI Shenzhen Co., Limited | 287 |
28 |
| President and Fellows of Harvard College | 6013 |
24 |
| 10X Genomics, Inc. | 1261 |
18 |
| GigaGen, Inc. | 66 |
18 |
| University of Washington | 2361 |
17 |
| Fred Hutchinson Cancer Center | 458 |
17 |
| The Regents of the University of California | 20172 |
16 |
| The Board of Trustees of the Leland Stanford Junior University | 6500 |
15 |
| Janssen Biotech, Inc. | 1568 |
14 |
| Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 287 |
14 |
| Illumina Cambridge Limited | 671 |
13 |
| Massachusetts Institute of Technology | 10127 |
12 |
| Life Technologies Corporation | 3331 |
12 |
| The General Hospital Corporation | 4784 |
11 |
| 1859, Inc. | 16 |
11 |
| Roche Sequencing Solutions, Inc. | 664 |
10 |
| Adimab, LLC | 146 |
9 |
| Other owners | 883 |